Curaleaf Posts $260.3 Million In Q1 Revenue, Beating Analyst Expectations

Curaleaf Holdings (CSE: CURA) this evening reported its first quarter financial results, with the company reporting total revenue of $260.3 million, beating consensus estimates. Adjusted EBITDA meanwhile came in at $62.6 million, beating consensus estimates of $60.2 million.

Revenues reported for the quarter represents a beat on the prior guidance of $250 to $255 million, while also marking a 13% gain from the fourth quarter revenue figure of $230.3 million. Year over year meanwhile revenue at Curaleaf grew from $96.5 million, a 170% increase.

Gross margins on cannabis sales meanwhile hit 49%, with cost of goods sold coming in at $131.9 million, representing a gross profit of $128.0 million before the impact of biological assets. After operating expenditures of $107.1 million, Curaleaf reported an income from operations of $33.7 million.

However, after factoring in interest expense of $12.2 million, interest expenses related to lease liabilities of $8.6 million, and income tax expenses of $30.7 million, the company recorded a net loss of $17.2 million.

Looking to the balance sheet, Curaleaf currently has $314.6 million in cash on the books, as well as receivables of $33.8 million and inventories of $237.3 million. The company currently has total current assets of $718.5 million. Comparatively, the company has current liabilities of $238.0 million, of which the largest portion, $110.1 million, is attributable to income tax payable, followed by accrued expenses of $54.4 million.

In terms of outlook, CEO Joe Bayern stated, “With our revenue projected to increase to $305 million to $315 million in the second quarter, we also expect to generate significant improvements in terms of achieving positive net income and positive operating cash flows in the back half of 2021.”

Curaleaf Holdings last traded at $17.35 on the CSE.


Information for this briefing was found via Sedar and Curaleaf Holdings. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Curaleaf’s Alabama Cannabis License Application May Have Used A Dead Applicant

Curaleaf’s attempt to obtain a medical cannabis license in Alabama has been met with controversy...

Saturday, September 23, 2023, 11:52:00 AM

Curaleaf Cries Misquote, Claims Boris Jordan Never Said Firm Will Not Pay Taxes

Curaleaf Holdings (TSX: CURA) has refuted claims of being misquoted by Bloomberg in a recent...

Friday, March 8, 2024, 07:32:00 AM

Curaleaf Amends Terms of Select Brand Acquisition

Curaleaf Holdings (CSE: CURA) announced this morning that certain terms and conditions have changed related...

Wednesday, October 30, 2019, 08:58:09 AM

Curaleaf Closes Acres Cannabis Purchase

Curaleaf Holdings (CSE: CURA) has finally completed its acquisition of Acres Cannabis of Nevada. The...

Friday, January 3, 2020, 08:43:12 AM

Curaleaf To Pay $211 Million In Cash For Arizona Operator

One week after announcing its acquisition of a single dispensary in the state of Arizona,...

Wednesday, December 29, 2021, 07:46:29 AM